Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications | 12 | 2022 | 286 | 4.780 |
Why?
|
| Depression | 23 | 2022 | 943 | 3.070 |
Why?
|
| Opioid-Related Disorders | 10 | 2022 | 298 | 2.990 |
Why?
|
| Internship and Residency | 16 | 2019 | 596 | 2.700 |
Why?
|
| Analgesics, Opioid | 7 | 2022 | 498 | 2.220 |
Why?
|
| Pregnancy | 24 | 2023 | 2334 | 1.700 |
Why?
|
| Opiate Substitution Treatment | 5 | 2022 | 57 | 1.690 |
Why?
|
| Burnout, Professional | 4 | 2021 | 64 | 1.690 |
Why?
|
| Buprenorphine | 4 | 2022 | 67 | 1.640 |
Why?
|
| Neonatal Abstinence Syndrome | 4 | 2022 | 27 | 1.620 |
Why?
|
| Depressive Disorder | 9 | 2017 | 621 | 1.560 |
Why?
|
| Pregnant Women | 4 | 2020 | 50 | 1.480 |
Why?
|
| Peripartum Period | 2 | 2022 | 15 | 1.440 |
Why?
|
| Telemedicine | 4 | 2023 | 700 | 1.400 |
Why?
|
| Psychiatry | 3 | 2021 | 112 | 1.380 |
Why?
|
| Physicians | 6 | 2019 | 324 | 1.360 |
Why?
|
| Parents | 2 | 2021 | 312 | 1.190 |
Why?
|
| Depression, Postpartum | 3 | 2017 | 9 | 1.170 |
Why?
|
| Sex Factors | 6 | 2021 | 1266 | 1.100 |
Why?
|
| Mental Disorders | 3 | 2022 | 659 | 1.090 |
Why?
|
| Substance-Related Disorders | 5 | 2023 | 1242 | 1.020 |
Why?
|
| Female | 51 | 2023 | 38074 | 0.990 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2022 | 154 | 0.930 |
Why?
|
| Pain Management | 3 | 2021 | 186 | 0.840 |
Why?
|
| Humans | 62 | 2023 | 68618 | 0.840 |
Why?
|
| Adult | 35 | 2021 | 21403 | 0.820 |
Why?
|
| Anxiety | 3 | 2022 | 422 | 0.810 |
Why?
|
| Work-Life Balance | 1 | 2021 | 1 | 0.800 |
Why?
|
| Students, Medical | 5 | 2019 | 210 | 0.780 |
Why?
|
| Stress, Psychological | 8 | 2022 | 824 | 0.780 |
Why?
|
| Prenatal Care | 2 | 2021 | 117 | 0.770 |
Why?
|
| Puerperal Disorders | 1 | 2021 | 20 | 0.760 |
Why?
|
| Suicidal Ideation | 5 | 2020 | 106 | 0.710 |
Why?
|
| Workplace | 2 | 2019 | 75 | 0.690 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 581 | 0.660 |
Why?
|
| Chronic Pain | 2 | 2017 | 110 | 0.640 |
Why?
|
| Family Conflict | 1 | 2017 | 6 | 0.610 |
Why?
|
| Pain | 1 | 2021 | 472 | 0.600 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 772 | 0.600 |
Why?
|
| Surveys and Questionnaires | 12 | 2021 | 2800 | 0.590 |
Why?
|
| Work Schedule Tolerance | 2 | 2017 | 18 | 0.580 |
Why?
|
| Sleep | 3 | 2022 | 263 | 0.580 |
Why?
|
| Oxycodone | 1 | 2017 | 10 | 0.580 |
Why?
|
| Nurse Midwives | 1 | 2016 | 21 | 0.560 |
Why?
|
| Depressive Disorder, Major | 4 | 2015 | 439 | 0.560 |
Why?
|
| Internet | 2 | 2018 | 390 | 0.560 |
Why?
|
| Methadone | 3 | 2022 | 32 | 0.550 |
Why?
|
| Students | 1 | 2018 | 233 | 0.550 |
Why?
|
| Prescription Drugs | 2 | 2017 | 71 | 0.510 |
Why?
|
| Women's Health | 3 | 2023 | 148 | 0.510 |
Why?
|
| Infant, Newborn | 5 | 2022 | 2455 | 0.500 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2018 | 435 | 0.500 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 216 | 0.500 |
Why?
|
| Prospective Studies | 10 | 2022 | 3705 | 0.450 |
Why?
|
| Medical Staff | 1 | 2013 | 5 | 0.440 |
Why?
|
| Progesterone | 2 | 2019 | 115 | 0.440 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2013 | 34 | 0.440 |
Why?
|
| Hydrocortisone | 3 | 2022 | 291 | 0.420 |
Why?
|
| Resilience, Psychological | 1 | 2013 | 43 | 0.420 |
Why?
|
| Pregnancy Outcome | 1 | 2013 | 157 | 0.420 |
Why?
|
| Workload | 1 | 2013 | 103 | 0.410 |
Why?
|
| Self Medication | 1 | 2012 | 25 | 0.410 |
Why?
|
| Longitudinal Studies | 9 | 2019 | 1054 | 0.400 |
Why?
|
| Male | 24 | 2022 | 37321 | 0.400 |
Why?
|
| Anxiety Disorders | 4 | 2018 | 426 | 0.370 |
Why?
|
| Referral and Consultation | 4 | 2021 | 383 | 0.360 |
Why?
|
| Young Adult | 8 | 2020 | 5717 | 0.330 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 445 | 0.330 |
Why?
|
| Premenstrual Syndrome | 1 | 2008 | 4 | 0.310 |
Why?
|
| United States | 8 | 2022 | 7367 | 0.300 |
Why?
|
| Cohort Studies | 7 | 2022 | 2358 | 0.290 |
Why?
|
| Tobacco Use | 2 | 2019 | 98 | 0.290 |
Why?
|
| Estradiol | 1 | 2008 | 176 | 0.280 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2018 | 57 | 0.280 |
Why?
|
| Guideline Adherence | 2 | 2021 | 287 | 0.280 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2022 | 150 | 0.280 |
Why?
|
| Pituitary-Adrenal System | 3 | 2022 | 138 | 0.280 |
Why?
|
| Child | 4 | 2023 | 6405 | 0.280 |
Why?
|
| Risk Factors | 8 | 2020 | 5731 | 0.270 |
Why?
|
| Infant | 3 | 2022 | 2891 | 0.260 |
Why?
|
| Sleep Deprivation | 2 | 2017 | 81 | 0.260 |
Why?
|
| Adolescent | 6 | 2020 | 8912 | 0.250 |
Why?
|
| Medical Errors | 2 | 2017 | 80 | 0.240 |
Why?
|
| Epilepsy | 1 | 2008 | 336 | 0.230 |
Why?
|
| Prevalence | 7 | 2019 | 1619 | 0.230 |
Why?
|
| Health Status | 2 | 2020 | 429 | 0.220 |
Why?
|
| Craving | 2 | 2022 | 200 | 0.220 |
Why?
|
| Psychotherapy | 2 | 2016 | 253 | 0.210 |
Why?
|
| Education, Medical, Graduate | 3 | 2019 | 214 | 0.210 |
Why?
|
| Inflammation | 2 | 2019 | 1030 | 0.200 |
Why?
|
| Child Development | 2 | 2019 | 102 | 0.200 |
Why?
|
| Clonidine | 1 | 2021 | 66 | 0.200 |
Why?
|
| Family Relations | 1 | 2021 | 47 | 0.200 |
Why?
|
| Qualitative Research | 1 | 2023 | 369 | 0.190 |
Why?
|
| Journal Impact Factor | 1 | 2021 | 12 | 0.190 |
Why?
|
| Comprehensive Health Care | 1 | 2021 | 26 | 0.190 |
Why?
|
| Fetal Development | 2 | 2022 | 70 | 0.190 |
Why?
|
| Maternal Health Services | 1 | 2021 | 22 | 0.190 |
Why?
|
| North America | 1 | 2020 | 112 | 0.180 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2020 | 19 | 0.180 |
Why?
|
| Mothers | 2 | 2022 | 172 | 0.180 |
Why?
|
| Social Media | 1 | 2021 | 59 | 0.170 |
Why?
|
| Disease Progression | 2 | 2013 | 1038 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2021 | 2007 | 0.170 |
Why?
|
| Occludin | 1 | 2019 | 7 | 0.170 |
Why?
|
| Occupational Stress | 1 | 2019 | 1 | 0.170 |
Why?
|
| User-Computer Interface | 1 | 2021 | 230 | 0.170 |
Why?
|
| Comorbidity | 2 | 2021 | 1426 | 0.170 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 6 | 0.170 |
Why?
|
| Telomere Shortening | 1 | 2019 | 8 | 0.170 |
Why?
|
| Altitude | 1 | 2019 | 17 | 0.170 |
Why?
|
| Telephone | 2 | 2017 | 160 | 0.170 |
Why?
|
| Analgesia, Obstetrical | 1 | 2019 | 15 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2019 | 455 | 0.160 |
Why?
|
| Psychometrics | 1 | 2021 | 514 | 0.160 |
Why?
|
| Recurrence | 1 | 2021 | 948 | 0.160 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 91 | 0.160 |
Why?
|
| Linear Models | 1 | 2020 | 521 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 119 | 0.160 |
Why?
|
| Inpatients | 2 | 2017 | 208 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 626 | 0.160 |
Why?
|
| Cellular Senescence | 1 | 2019 | 112 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 92 | 0.160 |
Why?
|
| Internal Medicine | 1 | 2019 | 118 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 438 | 0.150 |
Why?
|
| Presenteeism | 1 | 2017 | 7 | 0.150 |
Why?
|
| Neuroticism | 2 | 2019 | 3 | 0.150 |
Why?
|
| Membrane Cofactor Protein | 1 | 2017 | 7 | 0.150 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 86 | 0.150 |
Why?
|
| Pandemics | 1 | 2021 | 352 | 0.150 |
Why?
|
| Needs Assessment | 1 | 2019 | 186 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2017 | 782 | 0.150 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 3259 | 0.150 |
Why?
|
| Physicians, Women | 1 | 2017 | 23 | 0.150 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 43 | 0.150 |
Why?
|
| Bacterial Translocation | 1 | 2017 | 27 | 0.150 |
Why?
|
| Vitamin D | 1 | 2022 | 516 | 0.150 |
Why?
|
| Universities | 1 | 2018 | 191 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 101 | 0.150 |
Why?
|
| Bipolar Disorder | 1 | 2020 | 307 | 0.150 |
Why?
|
| Job Satisfaction | 2 | 2018 | 62 | 0.150 |
Why?
|
| Premature Birth | 1 | 2019 | 150 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 193 | 0.140 |
Why?
|
| Cocaine | 1 | 2022 | 555 | 0.140 |
Why?
|
| Parturition | 1 | 2016 | 15 | 0.140 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 79 | 0.140 |
Why?
|
| Affect | 2 | 2017 | 218 | 0.140 |
Why?
|
| Middle Aged | 6 | 2021 | 21147 | 0.140 |
Why?
|
| Heart Rate | 1 | 2019 | 568 | 0.140 |
Why?
|
| Narration | 1 | 2016 | 29 | 0.140 |
Why?
|
| Breast Feeding | 2 | 2019 | 159 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 261 | 0.140 |
Why?
|
| Health Personnel | 1 | 2019 | 286 | 0.140 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 136 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 425 | 0.130 |
Why?
|
| Counseling | 1 | 2017 | 280 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2020 | 7029 | 0.130 |
Why?
|
| Mental Health Services | 1 | 2017 | 199 | 0.130 |
Why?
|
| Health Policy | 1 | 2017 | 221 | 0.120 |
Why?
|
| Decision Making | 1 | 2018 | 410 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 214 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 504 | 0.120 |
Why?
|
| Phototherapy | 1 | 2014 | 28 | 0.120 |
Why?
|
| Nicotine | 1 | 2017 | 350 | 0.120 |
Why?
|
| Life Change Events | 2 | 2016 | 223 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2020 | 1342 | 0.110 |
Why?
|
| Suicide | 1 | 2014 | 116 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 19 | 0.110 |
Why?
|
| Accreditation | 1 | 2013 | 72 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 64 | 0.110 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 805 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2019 | 3187 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2022 | 7277 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2013 | 180 | 0.100 |
Why?
|
| Rape | 1 | 2013 | 180 | 0.100 |
Why?
|
| Inservice Training | 1 | 2012 | 68 | 0.100 |
Why?
|
| Family | 1 | 2013 | 293 | 0.090 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2010 | 51 | 0.090 |
Why?
|
| Mood Disorders | 2 | 2020 | 132 | 0.090 |
Why?
|
| Medicine | 1 | 2010 | 52 | 0.090 |
Why?
|
| Saliva | 2 | 2022 | 142 | 0.090 |
Why?
|
| Smoking | 1 | 2017 | 1452 | 0.080 |
Why?
|
| South Carolina | 3 | 2021 | 2752 | 0.080 |
Why?
|
| Brief Psychiatric Rating Scale | 2 | 2019 | 8 | 0.080 |
Why?
|
| Mass Screening | 3 | 2020 | 843 | 0.080 |
Why?
|
| Smoking Cessation | 1 | 2017 | 1034 | 0.080 |
Why?
|
| Aged | 3 | 2020 | 14862 | 0.080 |
Why?
|
| Genotype | 1 | 2010 | 786 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 711 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 627 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 2279 | 0.070 |
Why?
|
| PubMed | 1 | 2023 | 21 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2013 | 1506 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 20 | 0.050 |
Why?
|
| Parenting | 1 | 2023 | 91 | 0.050 |
Why?
|
| Data Collection | 1 | 2002 | 420 | 0.050 |
Why?
|
| Intelligence | 1 | 2019 | 45 | 0.040 |
Why?
|
| Outpatients | 1 | 2020 | 127 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 25 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 37 | 0.040 |
Why?
|
| Permeability | 1 | 2019 | 131 | 0.040 |
Why?
|
| Depersonalization | 1 | 2018 | 4 | 0.040 |
Why?
|
| Substance Abuse Detection | 1 | 2019 | 66 | 0.040 |
Why?
|
| Compassion Fatigue | 1 | 2018 | 2 | 0.040 |
Why?
|
| Education | 1 | 2019 | 83 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2013 | 257 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 219 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 502 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2020 | 340 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 4655 | 0.040 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 122 | 0.040 |
Why?
|
| Anhedonia | 1 | 2017 | 15 | 0.040 |
Why?
|
| General Surgery | 1 | 2017 | 95 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2017 | 67 | 0.040 |
Why?
|
| New England | 1 | 2016 | 16 | 0.040 |
Why?
|
| Suicide, Attempted | 1 | 2017 | 72 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 239 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 201 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2017 | 107 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2019 | 403 | 0.030 |
Why?
|
| Drug Overdose | 1 | 2017 | 67 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 1851 | 0.030 |
Why?
|
| Rural Population | 1 | 2019 | 398 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 170 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2016 | 130 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2019 | 310 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 652 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 729 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 371 | 0.030 |
Why?
|
| Pediatrics | 1 | 2017 | 341 | 0.030 |
Why?
|
| Self Concept | 1 | 2015 | 132 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 947 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1293 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 307 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 123 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 951 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1465 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1593 | 0.020 |
Why?
|
| Office Visits | 1 | 2002 | 83 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 1738 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 848 | 0.010 |
Why?
|